Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

• Published in: Internal and emergency medicine Vol. 17; no. 1; pp. 135 - 139
• Main Authors: Başcı, Semih, Ata, Naim, Altuntaş, Fevzi, Yiğenoğlu, Tuğçe Nur, Dal, Mehmet Sinan, Korkmaz, Serdal, Namdaroğlu, Sinem, Baştürk, Abdülkadir, Hacıbekiroğlu, Tuba, Doğu, Mehmet Hilmi, Berber, İlhami, Dal, Kürşat, Erkurt, Mehmet Ali, Turgut, Burhan, Çelik, Osman, Ülgü, Mustafa Mahir, Birinci, Şuayip
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.01.2022; Springer Nature B.V
• Subjects: Age; Blood cancer; Cancer; Coronaviruses; COVID-19; COVID-19 : diagnosis; Hematologic Neoplasms - complications; Humans; Im - Original; Intensive Care Units; Internal Medicine; management and prognosis; Mechanical ventilation; Medicine; Medicine & Public Health; Neoplasms - complications; Patients; Population studies; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Statistical analysis; COVID-19; Solid tumor; SARS-CoV-2; Hematologic cancer

Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course compared to the general population. However, no randomized study compared the clini...